Vident Investment Advisory, LLC Amarin Corp Plcuk Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$1.12 - $1.49 $11,467 - $15,256
10,239 New
10,239 $12,000
Q4 2022

Feb 14, 2023
BUY
$1.07 - $1.34 $14,436 - $18,079
13,492 New
13,492 $16,000
Q2 2020

Jul 17, 2020
SELL
$4.78 - $8.26 $288,621 - $498,747
-60,381 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$4.0 - $21.53 $241,524 - $1.3 Million
60,381 New
60,381 $242,000

Others Institutions Holding AMRN

# of Institutions
177
Shares Held
65.1M
Call Options Held
258K
Put Options Held
98K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $202M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email